Identification of structurally diverse FSP1 inhibitors that sensitize cancer cells to ferroptosis
- 12 May 2023
- journal article
- research article
- Published by Elsevier in Cell Chemical Biology
- Vol. 30 (9) , 1090-1103.e7
Abstract
No abstract availableKeywords
All Related Versions
This publication has 55 references indexed in Scilit:
- Systematic Quantification of Population Cell Death Kinetics in Mammalian CellsCell Systems, 2017
- Dihydroartemisinin (DHA) induces ferroptosis and causes cell cycle arrest in head and neck carcinoma cellsCancer Letters, 2016
- Activation of the p62‐Keap1‐NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cellsHepatology, 2015
- Ferroptosis as a p53-mediated activity during tumour suppressionNature, 2015
- Modeling human carcinomas: Physiologically relevant 3D models to improve anti-cancer drug developmentAdvanced Drug Delivery Reviews, 2014
- Regulation of Ferroptotic Cancer Cell Death by GPX4Cell, 2014
- Glutamine Sensitivity Analysis Identifies the xCT Antiporter as a Common Triple-Negative Breast Tumor Therapeutic TargetCancer Cell, 2013
- NRF2 and cancer: the good, the bad and the importance of contextNature Reviews Cancer, 2012
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell DeathCell, 2012
- Artemisinins: their growing importance in medicineTrends in Pharmacological Sciences, 2008